Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-23

Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of Elagolix tablets for endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elagolix (elagolix)

Snippet

Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Conditions: Endometriosis | Phase 3 | Status: COMPLETED